Interpenetrating polymer network hydrogel

US11759549B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11759549-B2
Application numberUS-201816107708-A
CountryUS
Kind codeB2
Filing dateAug 21, 2018
Priority dateAug 21, 2017
Publication dateSep 19, 2023
Grant dateSep 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An interpenetrating polymer network (IPN) structured hydrogel includes a crosslinked first natural polymer macromer with a first elasticity and an interpenetrating network of crosslinked second natural polymer macromers having a second elasticity higher than the first elasticity, the IPN structured hydrogel being cytocompatible, and, upon degradation, produce substantially non-toxic products.

First claim

Opening claim text (preview).

Having described the invention, I claim: 1. A composition comprising: a triple-network hydrogel having three types of crosslinking networks that includes crosslinked first natural polymer macromers with a first elasticity and a homogenously distributed interpenetrating network of crosslinked second natural polymer macromers having a second elasticity higher than the first elasticity, the triple-network hydrogel being cytocompatible, and, upon degradation, produce substantially non-toxic products, wherein the first polymer macromers are oxidized alginates and the second polymer macromers are acrylated and/or methacrylated gelatin macromers, wherein the first natural polymer macromers are crosslinked with a first agent to form a first crosslinking network, and the second natural polymer macromer are crosslinked with a second agent different than the first agent to form a second crosslinking network, wherein the first agent crosslinks the first natural polymer macromers but not the second natural polymer macromers, and the second agent crosslinks the second natural polymer macromers but not the first natural polymer macromers, and wherein aldehyde groups of the oxidized acrylates form imine-bonds with amine groups of the acrylated and/or methacrylated gelatin macromers to form a third crosslinking network, and wherein a plurality of cells are encapsulated within the hydrogel and mechanical stimulation of the hydrogel enhances cell proliferation and differentiation. 2. The composition of claim 1 , wherein the elasticity of the hydrogel is substantially maintained during degradation. 3. The composition of claim 1 , wherein the first natural polymer macromers are ionically crosslinkable with the first agent. 4. The composition of claim 1 , wherein the second natural polymer macromers are photocrosslinkable with the second agent. 5. The composition of claim 1 , further comprising at least one bioactive agent. 6. The composition of claim 1 , wherein the cells comprise progenitor cells, undifferentiated cells and/or differentiated cells. 7. The composition of claim 6 , wherein the cells include mesenchymal stem cells. 8. A composition comprising: a triple-network hydrogel having three types of crosslinking networks that includes a crosslinked first natural polymer macromers with a first elasticity and a homogenously distributed interpenetrating network of crosslinked second natural polymer macromers having a second elasticity higher than the first elasticity, the triple-network hydrogel being cytocompatible, and, upon degradation, produce substantially non-toxic products, wherein the elasticity of the hydrogel is substantially maintained during degradation, wherein the first polymer macromers are oxidized alginates and the second polymer macromers are acrylated and/or methacrylated gelatin macromers, wherein the first natural polymer macromers are crosslinked with a first agent to form a first crosslinking network and the second natural polymer macromer are crosslinked with a second agent different than the first agent to form a second crosslinking network, wherein the first agent crosslinks the first natural polymer macromers but not the second natural polymer macromers, and the second agent crosslinks the second natural polymer macromers but not the first natural polymer macromers, and wherein aldehyde groups of the oxidized acrylates form imine-bonds with amine groups of the acrylated and/or methacrylated gelatin macromers to form a third crosslinking network, and wherein a plurality of cells are encapsulated within the hydrogel and mechanical stimulation of the hydrogel enhances cell proliferation and differentiation. 9. The composition of claim 8 , wherein the first natural polymer macromers are ionically crosslinkable with the first agent. 10. The composition of claim 8 , wherein the second natural polymer macromers are photocrosslinkable with the second agent. 11. The composition of claim 8 , further comprising at least one bioactive agent.

Assignees

Inventors

Classifications

  • A61L27/52Primary

    Hydrogels or hydrocolloids · CPC title

  • A61L27/44Primary

    having a macromolecular matrix · CPC title

  • Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates · CPC title

  • derived from horn, hoofs, hair, skin or leather · CPC title

  • Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11759549B2 cover?
An interpenetrating polymer network (IPN) structured hydrogel includes a crosslinked first natural polymer macromer with a first elasticity and an interpenetrating network of crosslinked second natural polymer macromers having a second elasticity higher than the first elasticity, the IPN structured hydrogel being cytocompatible, and, upon degradation, produce substantially non-toxic products.
Who is the assignee on this patent?
Univ Case Western Reserve
What technology area does this patent fall under?
Primary CPC classification A61L27/52. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).